Variations in L-dopa absorption. Report of a parkinsonian patient with high plasma dopa concentration after therapeutical L-dopa dose.
D000284:Administration, Oral; D000368:Aged; D002250:Carbon Radioisotopes; D003653:Decarboxylation; D004295:Dihydroxyphenylalanine / Q000097:blood* / Q000134:cerebrospinal fluid / Q000652:urine; D004298:Dopamine / Q000097:blood / Q000134:cerebrospinal fluid; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007980:Levodopa / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D010649:Phenylalanine / Q000097:blood; D013268:Stimulation, Chemical; D013431:Sulfates / Q000097:blood; D014443:Tyrosine / Q000097:blood
D002250:Carbon Radioisotopes; D013431:Sulfates; D014443:Tyrosine; D007980:Levodopa; D010649:Phenylalanine; D004295:Dihydroxyphenylalanine; D004298:Dopamine